Clinical Trial Update: A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating guselkumab for palmoplantar-non-pustular psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED